AstraZeneca trial failure raises bigger questions about its portfolio
AstraZenecaWainua's failed final trial was never expected to have a major financial impact on the company. Most analysts estimate that…
Biotechnology and pharmaceuticals
Abivax receives $920 million in cash to prepare for US launch: CEO
AbivaxThe latest round of funding allows the biotech to move toward launching its intestinal disease drug in the United States…
AstraZeneca shares fall 9% after heart drug trial falls short of target
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…
FDA allows Philip Morris-owned Zyn to be marketed as less harmful cigarettes
The Food and Drug Administration on Tuesday authorized Philip MorrisZyn's proprietary Zyn nicotine pouches will be marketed as less harmful…
Jim Cramer Says This Former Covid Market Favorite May Finally Be Invested Again
modern Expanding the portfolio beyond infectious diseases is giving investors a new reason to own stocks after years of uncertainty…
Walmart and CVS step in to help seniors
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Abivax shares soar after new data on drugs for intestinal diseases
Shares of a French biotechnology company Abivax surged on Tuesday after it released new data on its lead drug for…
Medicare Will Soon Cover Obesity Medications, But Many Seniors May Not Know It
Wegovy weight loss treatment injectable pens, manufactured by Novo Nordisk A/S, on display during a press conference in Mumbai, India,…
Centene to offer terminations to some employees
Sheldon Cooper | Light rocket | fake images rye said it offered buyouts to some employees on Monday, as the…
Chan Zuckerberg Biohub to open new round of funding for rare diseases
Biohub, a nonprofit research organization funded by the Chan Zuckerberg Initiative, announced Thursday that it will open another round of…